Moreover, dendritic cells are known to preferentially utilize Axl for efferocytosis, with current MERTK inhibitors showing good selectivity for MERTK over the other TAM receptors [89,251], indicating that TAM-dependent uptake of tumor antigens by dendritic cells may be minimally affected by MERTK inhibition. The gene discussed is MERTK; the disease is neoplasm.